Company profile
NEUROCRINE BIOSCIENCES INC
NASDAQ:NBIXBiotechnology: Biological Products (No Diagnostic Substances)
Drug pipeline (12)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| INGREZZA | approved | $656.9MQ1 2026 | 0 | — |
| CRENESSITY | approved | $153.3MQ1 2026 | 6 | approved |
| INGREZZA SPRINKLE | approved | — | 0 | — |
| VALBENAZINE | phase4 | — | 27 | active |
| DIRECLIDINE | phase3 | — | 6 | active |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (103)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT02274558 | phase3 | completed | 2014-10-01 | 2015-09-01 | Neurocrine Biosciences | A Phase 3 Study of NBI-98854 for the Treatment of Tardive Dyskinesia |
| NCT03319953 | phase2 | completed | 2017-12-21 | 2019-09-11 | Neurocrine Biosciences | A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia |
| NCT02959892 | phase1 | completed | 2016-12-05 | 2017-05-30 | Neurocrine Biosciences | A Single-Dose Positron Emission Tomography (PET) Study to Determine the Effect of TAK-041 on Amphetamine-Induced Dopamine Release in the Central Nervous System (CNS) |
| NCT03343327 | phase1 | completed | 2018-02-19 | 2018-04-20 | Neurocrine UK Limited | A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects |
| NCT03311932 | phase1 | completed | 2018-04-16 | 2018-07-13 | Neurocrine UK Limited | A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects |
FDA applications (4)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 218808 | 2024-12-13 | NDA | NEUROCRINE BIOSCIENCES INC | |||||
Loading… | ||||||||
| NDA 218820 | 2024-12-13 | NDA | NEUROCRINE BIOSCIENCES INC | |||||
Loading… | ||||||||
| NDA 218390 | 2024-04-30 | NDA | NEUROCRINE BIOSCIENCES INC | |||||
Loading… | ||||||||
| NDA 209241 | 2017-04-11 | NDA | NEUROCRINE BIOSCIENCES INC | |||||
Loading… | ||||||||